Abstract
Levetiracetam is a well-tolerated anticonvulsant drug, but associated with some adverse effects. To date, there is no report of hypoglycemia associated with levetiracetam. We report the case of a 6-year-old female patient who developed symptomatic hypoglycemia after initiation of treatment with levetiracetam for her refractory status epilepticus and we review the literature to identify other reports of hypoglycemia. Associated with levetiracetam in children in order to highlight this rare adverse effect and a possible dose effect. Hypoglycemia is a rare and underestimated adverse effect of Levetiracetam and which must be taken into account and treated appropriately, in particular when high doses are given; allowing a saving of a multiple of unnecessary additional examinations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
